Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
New global partnership aims to turn PepLib’s peptide tech into therapies that could reshape treatment and longevity. Think of tiny molecular “messengers” that can precisely target disease inside the body. That…
Read guide →For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1 Participants taking retatrutide 12 mg lost an average of 36.6 lbs (16.8%) No weight l…
Read guide →BioPharma PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly 06 Februa…
Read guide →Last reviewed: May 12, 2026 Last updated: May 12, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker ins…
Read guide →Share on Pinterest A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty Images Eli Lilly recently anno…
Read guide →“Obesity affects approximately one billion people in the world,” Eli Lilly’s Michael Kopach told audiences at TIDES USA in Boston, Massachusetts. “It’s the leading risk factor for type II diabetes, contributin…
Read guide →Sources point to a single instance in which experimental therapy retatrutide was provided for ‘compassionate use’ Alex Hogan/STAT Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship be…
Read guide →A conversation with Matt Foster, Darragh McDonagh, and Kevin Seibert, Eli Lilly and Company Photo courtesy of Eli Lilly and Company. Eli Lilly and Company’s approach to high-throughput peptide manufacturing ha…
Read guide →In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving ≥ 30% weight loss, a level long associated with bariatric surgery Individu…
Read guide →An article from Dive Brief // Obesity drugs Participants who stayed on the drug lost around one-quarter of their body weight, potentially setting a new benchmark for rivals like Novo Nordisk. Published May 21,…
Read guide →